ai-explainability
(3)
Intelligencia AI
Intelligencia AI is a New York-based artificial intelligence company that helps pharmaceutical and biotech organizations predict the probability of technical and regulatory success (PTRS) for drug candidates. Its patented SaaS platform harmonizes more than 1.5 billion clinical and biological data points to score how likely a drug is to advance through clinical phases and win regulatory approval, with reported prospective accuracy above 80%. The company gives R&D, business development, and portfolio teams transparent, explainable AI to de-risk investment decisions in drug development.
dMetrics
dMetrics is an AI company that builds Minsky, a natural-language-processing platform letting non-technical subject-matter experts create their own AI models to read, track, and analyze huge volumes of messy text - without writing code. Founded by two MIT machine-learning PhDs, the company started by decoding healthcare conversations across social media and now serves financial, pharmaceutical, and public-sector customers, including a five-year, $99.5M U.S. Department of Defense production contract for open-source threat analysis.
Vianai Systems, Inc.
Vianai Systems is a Palo Alto-based enterprise AI company founded by Dr. Vishal Sikka - former CEO of Infosys and CTO of SAP - that builds human-centered AI platforms designed to make generative AI genuinely useful at scale. Its flagship product, hila, is a conversational AI analytics platform that lets C-suite executives query enterprise data in plain language, while its broader MLOps platform handles model explainability, drift detection, bias monitoring, and automatic retraining across industries including financial services, manufacturing, aerospace, and defense. Backed by $440 million in funding including investment from SoftBank Vision Fund 2, Vianai partners with TCS, Google Cloud, Cognizant, and Boomi to deploy trusted, responsible AI for the world's largest enterprises.